• The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
  • Subscribe
  • Sign in
  • Pharma
  • Medtech
  • Biotech
  • Science
  • Events
  • Careers
  • Jobs
  • Opinion & Debate
  • The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
Menu
  • Subscribe
  • Sign in
Advertisement

No 01 2018 – Coming soon

Malin Otmani

-

February 1, 2018

Share article on X
Share article on Linkedin

Updated: March 27, 2026, 01:04 pm

Published: February 1, 2018

Advertisement
Advertisement

Top stories

Intellectual Property – August 7, 2026

SynAct Pharma receives favorable US patent decision

The Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) has issued a favorable Decision on Appeal in U.S. patent application No. 18/065,702, Appeal No. 2026-000924, relating to an immediate-release solid oral dosage formulation of resomelagon (AP1189 acetate).

In a new job – August 7, 2026

He is the new CFO at Diamyd Medical

Diamyd Medical has announced that Mathias Skalmstad will take up the position of Chief Financial Officer at Diamyd Medical.

Global report – August 6, 2026

US FDA approves first mRNA flu shot from Moderna

The U.S. Food and Drug Administration (FDA) has approved mFLUSIVA (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.

In a new job – August 6, 2026

Oxcia appoints new Preclinical Director

“Sandra has been an invaluable member of the Oxcia team, combining scientific excellence with a deep understanding of inflammation as well as our development programs,” says Ulrika Bergman Warpman, CEO. “We are delighted to see her take on this leadership role as we finalize the pre-clinical program for OXC-201 and progress our earlier projects including […]

Follow NLS news
Follow us on XFollow us on LinkedinFollow us on Bluesky
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

Related posts

Intellectual Property - August 7, 2026

SynAct Pharma receives favorable US patent decision

The Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) has issued a favorable Decision on Appeal in U.S. patent application No. 18/065,702, Appeal No. 2026-000924, relating to an immediate-release solid oral dosage formulation of resomelagon (AP1189 acetate).

In a new job - August 7, 2026

He is the new CFO at Diamyd Medical

Diamyd Medical has announced that Mathias Skalmstad will take up the position of Chief Financial Officer at Diamyd Medical.

Global report - August 6, 2026

US FDA approves first mRNA flu shot from Moderna

The U.S. Food and Drug Administration (FDA) has approved mFLUSIVA (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.

In a new job - August 6, 2026

Oxcia appoints new Preclinical Director

“Sandra has been an invaluable member of the Oxcia team, combining scientific excellence with a deep understanding of inflammation as well as our development programs,” says Ulrika Bergman Warpman, CEO. “We are delighted to see her take on this leadership role as we finalize the pre-clinical program for OXC-201 and progress our earlier projects including […]

In a new job - August 5, 2026

SciBase’s CEO steps down

"SciBase is now entering a new phase where the strategy and foundation is in place, and I feel this is the right time to hand over responsibility to a new CEO," says Pia Renaudin.

Clinical Trials - August 4, 2026

Nykode Therapeutics presents preclinical data, optimized manufacturing, and durable clinical immunogenicity

Nykode Therapeutics has presented comprehensive preclinical and clinical data on VB10.NEO, its individualized neoantigen therapy (INT), at the Neoantigen Summit in Amsterdam, reinforcing the program as a differentiated platform ready for strategic partnership.

In a new job - August 4, 2026

EQL Pharma recruits new Chief Supply Chain Officer 

EQL has recruited Oskar Karmlid as its new Chief Supply Chain Officer (CSCO).

Sign up to our Newsletter!

I confirm that I want to subscribe to newsletters from Nordic Life Science and that Nordic Life Science has the right to save my email address. Read our privacy policy here

Read the latest issue!

Sign up for a subscription and read our latest digital issue today.

Sign up
Sign up

The leading life science news channel in the Nordic region.

© NLS Media Group AB – All rights reserved

Digital and print
  • The magazine
  • Subscribe
  • Newsletter
More information
  • About us
  • Contact
  • Advertising
Social media
  • LinkedIn
  • Bluesky
  • X
NLS Media Group AB

St Paulsgatan 13

118 46 Sweden

info@nlsnews.com

+46-8-588 941 51

  • Cookies
  • Data management and privacy policy

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.